uniQure (QURE) Current Taxes (2024 - 2025)
uniQure (QURE) recorded quarterly Current Taxes of $7.8 million in Q3 2025, up 2569.28% quarter-over-quarter from $293000.0 in Q4 2024.
uniQure (QURE) Current Taxes (2024 - 2025) Analysis & Trends
uniQure's Current Taxes history runs 2 years deep, the most recent figure standing at $7.8 million for Q3 2025.
- In Q3 2025, Current Taxes changed N/A year-over-year to $7.8 million; the TTM figure through Sep 2025 stood at $7.8 million (changed N/A YoY), while the FY2024 annual figure was $293000.0, changed N/A from the prior year.
- Current Taxes was $7.8 million for Q3 2025 at uniQure, up from $293000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $7.8 million in Q3 2025 to a low of $293000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.82 Mn |
| Dec 31, 2024 | 293,000.00 |